Kopran

Market Cap: Micro Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE082A01010
NSEID: KOPRAN
BSEID: 524280

INR

189.10

14.65 (8.4%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.52 lacs

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Divi's Lab.

Cipla

Kwality Pharma

Sun Pharma.Inds.

Torrent Pharma

Fermenta Biotec.

Shukra Pharma.

Kopran

Anuh Pharma

Mankind Pharma

Wanbury

Why is Kopran Ltd ?

Poor long term growth as Net Sales has grown by an annual rate of 11.59% and Operating profit at 12.53% over the last 5 years

Negative results in Dec 24

PBT LESS OI(Q) At Rs 13.69 cr has Fallen at -24.28%
PAT(Q) At Rs 10.40 cr has Fallen at -34.1%

Stock is technically in a Mildly Bearish range

The stocks MACD and Bollinger Band technical factors are also Bearish

Falling Participation by Institutional Investors

Institutional investors have decreased their stake by -0.67% over the previous quarter and collectively hold 0.87% of the company
These investors have better capability and resources to analyse fundamentals of companies than most retail investors

Below par performance in long term as well as near term

Along with generating -31.47% returns in the last 1 year, the stock has also underperformed BSE 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Kopran for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Kopran

-31.84%

-0.60

52.49%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.59%

EBIT Growth (5y)

12.53%

EBIT to Interest (avg)

9.03

Debt to EBITDA (avg)

1.32

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

1.19

Tax Ratio

25.11%

Dividend Payout Ratio

28.38%

Pledged Shares

Institutional Holding

0.87%

ROCE (avg)

14.17%

ROE (avg)

13.89%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.69

EV to EBIT

16.21

EV to EBITDA

12.88

EV to Capital Employed

1.56

EV to Sales

1.49

PEG Ratio

1.01

Dividend Yield

1.72%

ROCE (Latest)

10.37%

ROE (Latest)

10.64%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Mildly Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-8What is not working for the Company

PBT LESS OI(Q)

At Rs 13.69 cr has Fallen at -24.28%

PAT(Q)

At Rs 10.40 cr has Fallen at -34.1%

Loading Valuation Snapshot...

Here's what is not working for Kopran

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs 13.69 cr has Fallen at -24.28%

Year on Year (YoY)

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs 10.40 cr has Fallen at -34.1%

Year on Year (YoY)

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)